Author Question: Special aptitude tests: a. measure a homogenous area of ability. b. are generally used to ... (Read 58 times)

rachel9

  • Sr. Member
  • ****
  • Posts: 495
Special aptitude tests:
 
  a. measure a homogenous area of ability.
  b. are generally used to predict success in a specific vocational area of interest.
  c. are frequently used as a screening process to assess one's ability to perform a certain job or to master a new skill at work.
  d. All of these are characteristics of special aptitude tests.
  e. None of these are characteristics of special aptitude tests.

Question 2

In contrast to the Differential Aptitude Test, The Differential Aptitude Battery for Personnel and Career Assessment (DAT PCA):
 
  a. uses stanines and percentiles.
  b. only has five tests.
  c. is focused on helping employers determine one's current ability and aptitude for learning new skills during training.
  d. All of these are characteristics of the DAT PCA.



ally

  • Sr. Member
  • ****
  • Posts: 331
Answer to Question 1

ANSWER: d

Answer to Question 2

ANSWER: c



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Multiple experimental evidences have confirmed that at the molecular level, cancer is caused by lesions in cellular DNA.

Did you know?

There are major differences in the metabolism of morphine and the illegal drug heroin. Morphine mostly produces its CNS effects through m-receptors, and at k- and d-receptors. Heroin has a slight affinity for opiate receptors. Most of its actions are due to metabolism to active metabolites (6-acetylmorphine, morphine, and morphine-6-glucuronide).

Did you know?

Most fungi that pathogenically affect humans live in soil. If a person is not healthy, has an open wound, or is immunocompromised, a fungal infection can be very aggressive.

Did you know?

Aspirin may benefit 11 different cancers, including those of the colon, pancreas, lungs, prostate, breasts, and leukemia.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library